Literature DB >> 33384961

Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma.

Bo Xiao1,2, Liyan Liu1,2, Aoyu Li1,2, Cheng Xiang1,2, Pingxiao Wang1,2, Hui Li1,2, Tao Xiao1,2.   

Abstract

Osteosarcoma is the most common malignant bone tumor in children and adolescence. Multiple immune-related genes have been reported in different cancers. The aim is to identify an immune-related gene signature for the prospective evaluation of prognosis for osteosarcoma patients. In this study, we evaluated the infiltration of immune cells in 101 osteosarcoma patients downloaded from TARGET using the ssGSEA to the RNA-sequencing of these patients, thus, high immune cell infiltration cluster, middle immune cell infiltration cluster and low immune cell infiltration cluster were generated. On the foundation of high immune cell infiltration cluster vs. low immune cell infiltration cluster and normal vs. osteosarcoma, we found 108 common differentially expressed genes which were sequentially submitted to univariate Cox and LASSO regression analysis. Furthermore, GSEA indicated some pathways with notable enrichment in the high- and low-immune cell infiltration cluster that may be helpful in understanding the potential mechanisms. Finally, we identified seven immune-related genes as prognostic signature for osteosarcoma. Kaplan-Meier analysis, ROC curve, univariate and multivariate Cox regression further confirmed that the seven immune-related genes signature was an innovative and significant prognostic factor independent of clinical features. These results of this study offer a means to predict the prognosis and survival of osteosarcoma patients with uncovered seven-gene signature as potential biomarkers.
Copyright © 2020 Xiao, Liu, Li, Xiang, Wang, Li and Xiao.

Entities:  

Keywords:  TARGET; gene; immune; osteosarcoma; prognostic; ssGSEA

Year:  2020        PMID: 33384961      PMCID: PMC7771722          DOI: 10.3389/fonc.2020.607622

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  34 in total

1.  Alpha-smooth muscle actin (ACTA2) is required for metastatic potential of human lung adenocarcinoma.

Authors:  Hye Won Lee; Young Mi Park; Se Jeong Lee; Hyun Jung Cho; Duk-Hwan Kim; Jung-Il Lee; Myung-Soo Kang; Ho Jun Seol; Young Mog Shim; Do-Hyun Nam; Hyeon Ho Kim; Kyeung Min Joo
Journal:  Clin Cancer Res       Date:  2013-08-30       Impact factor: 12.531

2.  Overexpression of SLC7A7 predicts poor progression-free and overall survival in patients with glioblastoma.

Authors:  Songhua Fan; Delong Meng; Tao Xu; Yuanyuan Chen; Jingkun Wang; Xiaoying Li; Hongyan Chen; Daru Lu; Juxiang Chen; Qing Lan
Journal:  Med Oncol       Date:  2013-02-14       Impact factor: 3.064

3.  CDCA7 promotes lung adenocarcinoma proliferation via regulating the cell cycle.

Authors:  Hongying Wang; Liang Ye; Ze Xing; Hanqing Li; Tangfeng Lv; Hongbing Liu; Fang Zhang; Yong Song
Journal:  Pathol Res Pract       Date:  2019-08-01       Impact factor: 3.250

4.  Identification and validation of immune-related lncRNA prognostic signature for breast cancer.

Authors:  Yong Shen; Xiaowei Peng; Chuanlu Shen
Journal:  Genomics       Date:  2020-02-19       Impact factor: 5.736

5.  Analysis of chemotherapy response programs in ovarian cancers by the next-generation sequencing technologies.

Authors:  Lihua Cheng; Wei Lu; Bhushan Kulkarni; Tanja Pejovic; Xiaowei Yan; Jung-Hsien Chiang; Leroy Hood; Kunle Odunsi; Biaoyang Lin
Journal:  Gynecol Oncol       Date:  2010-02-23       Impact factor: 5.482

6.  Robust enumeration of cell subsets from tissue expression profiles.

Authors:  Aaron M Newman; Chih Long Liu; Michael R Green; Andrew J Gentles; Weiguo Feng; Yue Xu; Chuong D Hoang; Maximilian Diehn; Ash A Alizadeh
Journal:  Nat Methods       Date:  2015-03-30       Impact factor: 28.547

7.  Identification Hub Genes in Colorectal Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Clinical Validation in vivo and vitro.

Authors:  Yihang Yuan; Ji Chen; Jue Wang; Ming Xu; Yunpeng Zhang; Peng Sun; Leilei Liang
Journal:  Front Oncol       Date:  2020-04-30       Impact factor: 6.244

8.  Identification of key candidate genes and biological pathways in bladder cancer.

Authors:  Xin Gao; Yinyi Chen; Mei Chen; Shunlan Wang; Xiaohong Wen; Shufang Zhang
Journal:  PeerJ       Date:  2018-12-04       Impact factor: 2.984

9.  The Anti-Tumor Effects of M1 Macrophage-Loaded Poly (ethylene glycol) and Gelatin-Based Hydrogels on Hepatocellular Carcinoma.

Authors:  Alberto Daniel Guerra; Oscar W H Yeung; Xiang Qi; W John Kao; Kwan Man
Journal:  Theranostics       Date:  2017-08-23       Impact factor: 11.556

10.  Immune-related prognosis biomarkers associated with osteosarcoma microenvironment.

Authors:  Weifeng Hong; Hong Yuan; Yujun Gu; Mouyuan Liu; Yayun Ji; Zifang Huang; Junlin Yang; Liheng Ma
Journal:  Cancer Cell Int       Date:  2020-03-16       Impact factor: 5.722

View more
  36 in total

1.  A Novel Glutamine Metabolism-Related Gene Signature in Prognostic Prediction of Osteosarcoma.

Authors:  Lu Wan; Wenchao Zhang; Zhongyue Liu; Zhimin Yang; Chao Tu; Zhihong Li
Journal:  Int J Gen Med       Date:  2022-02-01

2.  Integrated Analysis of ECT2 and COL17A1 as Potential Biomarkers for Pancreatic Cancer.

Authors:  Wen-Liang Huang; Shu-Fen Wu; Xiao Huang; Shan Zhou
Journal:  Dis Markers       Date:  2022-06-08       Impact factor: 3.464

3.  Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer.

Authors:  Jian Hou; Zhenquan Lu; Xiaobao Cheng; Runan Dong; Yi Jiang; Guoqing Wu; Genyi Qu; Yong Xu
Journal:  BMC Cancer       Date:  2022-06-30       Impact factor: 4.638

4.  Construction of a Novel Clinical Stage-Related Gene Signature for Predicting Outcome and Immune Response in Hepatocellular Carcinoma.

Authors:  Liu Yang; Long-Fei Zeng; Guo-Qing Hong; Qing Luo; Xing Lai
Journal:  J Immunol Res       Date:  2022-07-12       Impact factor: 4.493

5.  Identification of the Shared Gene Signatures and Biological Mechanism in Type 2 Diabetes and Pancreatic Cancer.

Authors:  Yifang Hu; Ni Zeng; Yaoqi Ge; Dan Wang; Xiaoxuan Qin; Wensong Zhang; Feng Jiang; Yun Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 5.555

6.  Development and Verification of a Hypoxic Gene Signature for Predicting Prognosis, Immune Microenvironment, and Chemosensitivity for Osteosarcoma.

Authors:  Fengfeng Wu; Juntao Xu; Mingchao Jin; Xuesheng Jiang; Jianyou Li; Xiongfeng Li; Zhuo Chen; Jiangbo Nie; Zhipeng Meng; Guorong Wang
Journal:  Front Mol Biosci       Date:  2022-01-05

7.  A novel immune-related gene signature predicting survival in sarcoma patients.

Authors:  Haoyu Ren; Alexandr V Bazhin; Elise Pretzsch; Sven Jacob; Haochen Yu; Jiang Zhu; Markus Albertsmeier; Lars H Lindner; Thomas Knösel; Jens Werner; Martin K Angele; Florian Bösch
Journal:  Mol Ther Oncolytics       Date:  2021-12-09       Impact factor: 7.200

8.  Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma.

Authors:  Jinpo Yang; Anran Zhang; Huan Luo; Chao Ma
Journal:  Sci Rep       Date:  2022-01-24       Impact factor: 4.996

9.  Global Characterization of Metabolic Genes Regulating Survival and Immune Infiltration in Osteosarcoma.

Authors:  Zhongpei Zhu; Min Zhang; Weidong Wang; Peng Zhang; Yuqiang Wang; Limin Wang
Journal:  Front Genet       Date:  2022-01-13       Impact factor: 4.599

10.  Effect of unfolded protein response on the immune infiltration and prognosis of transitional cell bladder cancer.

Authors:  Xiaokai Yan; Min Chen; Chiying Xiao; Jiandong Fu; Xia Sun; Zuohuai Hu; Hang Zhou
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.